-- Surgery 2 Question Bank: Topic 45 - Bladder Disorders (32 MCQs)
-- Category: Surgery 2 (a0000002-0000-0000-0000-000000000002)
-- Topic: Bladder Disorders (c0000045-0000-0000-0000-000000000045)

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES
('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The urinary bladder is lined by:', 'Squamous epithelium', 'Transitional epithelium (urothelium)', 'Columnar epithelium', 'Cuboidal epithelium', 'Pseudostratified epithelium', 'B', 'Bladder lined by transitional epithelium (urothelium) - specialized for stretch. Same epithelium lines renal pelvis, ureters, and proximal urethra. Gives rise to urothelial carcinoma.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The detrusor muscle is innervated primarily by:', 'Somatic nerves', 'Parasympathetic nerves (S2-S4) causing contraction', 'Sympathetic nerves only', 'Pudendal nerve', 'Hypogastric nerve only', 'B', 'Detrusor: smooth muscle, parasympathetic (pelvic splanchnic nerves S2-S4) causes contraction (voiding). Sympathetic relaxes detrusor and contracts bladder neck (storage). Voluntary control via pudendal.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Normal bladder capacity in adults is approximately:', '100-150 mL', '200-300 mL', '400-600 mL', '800-1000 mL', '1500 mL', 'C', 'Normal bladder capacity: 400-600 mL. First desire to void: 150-250 mL. Strong desire: 300-400 mL. Urgency: approaching capacity. Varies with age, conditions.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bladder cancer is most commonly of what histological type:', 'Squamous cell carcinoma', 'Transitional cell (urothelial) carcinoma', 'Adenocarcinoma', 'Small cell carcinoma', 'Sarcoma', 'B', 'Urothelial (TCC): 90% of bladder cancers in Western world. SCC (5%) - associated with chronic irritation, schistosomiasis. Adenocarcinoma (2%) - urachus, cystitis glandularis.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The most significant risk factor for bladder cancer is:', 'Alcohol', 'Cigarette smoking', 'Family history', 'Obesity', 'Red meat consumption', 'B', 'Smoking: accounts for 50% of bladder cancers. Aromatic amines excreted in urine. Risk persists after cessation. Other: occupational (dyes, rubber), cyclophosphamide, radiation, chronic irritation.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bladder cancer most commonly presents with:', 'Urinary frequency', 'Painless gross haematuria', 'Dysuria', 'Urinary retention', 'Incontinence', 'B', 'Painless haematuria: presenting symptom in 80-90%. Irritative symptoms (frequency, urgency, dysuria) in 20%. Any haematuria >40 years requires investigation (cystoscopy, imaging).', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Investigation of choice for suspected bladder cancer is:', 'Ultrasound alone', 'Cystoscopy with biopsy', 'CT scan only', 'Urine cytology alone', 'MRI bladder', 'B', 'Cystoscopy: gold standard for diagnosis. Visualizes tumour, location, number. Biopsy/TURBT for histology and staging. CT urogram for upper tract and staging. Cytology adjunct.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Non-muscle invasive bladder cancer (NMIBC) includes stages:', 'T2 and above', 'Ta, T1, and CIS', 'T3-T4', 'Any N positive', 'Metastatic only', 'B', 'NMIBC: Ta (papillary, non-invasive), T1 (invades lamina propria), CIS (flat, high-grade). 75-80% present as NMIBC. MIBC: T2+ (invades muscle). Different treatment approaches.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Initial treatment for non-muscle invasive bladder cancer is:', 'Radical cystectomy', 'Transurethral resection of bladder tumour (TURBT)', 'Chemotherapy', 'Radiation', 'Observation', 'B', 'TURBT: diagnostic and therapeutic. Complete resection of visible tumour. Include muscle in specimen for staging. Followed by risk stratification and adjuvant intravesical therapy.', 'easy', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Intravesical BCG therapy is indicated for:', 'Low-risk Ta tumours', 'High-risk NMIBC (high-grade, T1, CIS)', 'Muscle-invasive cancer', 'Metastatic disease', 'Squamous cell carcinoma', 'B', 'BCG: Bacillus Calmette-Guerin, live attenuated mycobacterium. For high-risk NMIBC: reduces recurrence and progression. Instilled weekly for 6 weeks then maintenance. CIS particularly responsive.', 'medium', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Standard treatment for muscle-invasive bladder cancer is:', 'TURBT alone', 'Radical cystectomy with neoadjuvant chemotherapy', 'Intravesical BCG', 'Observation', 'Alpha-blockers', 'B', 'MIBC treatment: neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy with urinary diversion. Alternative: bladder preservation (trimodal therapy: TURBT + chemoRT) in selected patients.', 'medium', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Radical cystectomy in males includes removal of:', 'Bladder only', 'Bladder, prostate, seminal vesicles, and pelvic lymph nodes', 'Bladder and kidneys', 'Bladder and ureters only', 'Prostate only', 'B', 'Male radical cystectomy: bladder, prostate, seminal vesicles, bilateral pelvic lymphadenectomy, urethra if indicated. Female: bladder, urethra, uterus, ovaries, anterior vaginal wall, lymph nodes.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Types of urinary diversion after cystectomy include:', 'Nephrostomy only', 'Ileal conduit, continent cutaneous pouch, or orthotopic neobladder', 'Dialysis', 'Suprapubic catheter permanent', 'Ureteral stents only', 'B', 'Urinary diversion: ileal conduit (incontinent, stoma bag), continent pouch (self-catheterize), orthotopic neobladder (voiding through urethra). Choice depends on patient factors, tumour location.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Schistosomiasis is associated with what type of bladder cancer:', 'Transitional cell carcinoma', 'Squamous cell carcinoma', 'Adenocarcinoma', 'Small cell carcinoma', 'Lymphoma', 'B', 'Schistosoma haematobium: chronic bladder infection â†’ SCC (not TCC). Endemic in Africa, Middle East. Egg deposition causes chronic inflammation. Declining with treatment programs.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Overactive bladder (OAB) is characterized by:', 'Stress incontinence', 'Urgency, with or without urge incontinence, usually with frequency and nocturia', 'Painless haematuria', 'Urinary retention', 'Fistula', 'B', 'OAB syndrome: urgency (key symptom), with/without urge incontinence, usually frequency and nocturia. Diagnosis of exclusion. Detrusor overactivity on urodynamics in many but not all.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'First-line treatment for overactive bladder includes:', 'Surgery', 'Behavioural therapy, bladder training, and antimuscarinic medications', 'Antibiotics', 'Alpha-blockers', 'Radiation', 'B', 'OAB treatment: behavioural (fluid management, bladder training, pelvic floor exercises), pharmacotherapy (antimuscarinics - oxybutynin, tolterodine; beta-3 agonists - mirabegron). Third-line: Botox, neuromodulation.', 'easy', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Stress urinary incontinence is caused by:', 'Detrusor overactivity', 'Urethral hypermobility and/or intrinsic sphincter deficiency', 'Neurological disease', 'Overflow', 'Fistula', 'B', 'Stress incontinence: involuntary leakage with exertion, coughing, sneezing. Due to urethral hypermobility (pelvic floor weakness) and/or intrinsic sphincter deficiency. Common in women postpartum.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment options for stress incontinence include:', 'Antimuscarinics', 'Pelvic floor exercises, midurethral sling, or colposuspension', 'Alpha-blockers', 'TURP', 'Cystectomy', 'B', 'Stress incontinence treatment: pelvic floor muscle training (first-line), duloxetine, surgery if conservative fails (midurethral sling most common - TVT, TOT; Burch colposuspension).', 'medium', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Neurogenic bladder can result from:', 'Kidney stones', 'Spinal cord injury, multiple sclerosis, or diabetes mellitus', 'Prostate cancer', 'Bladder stones', 'Haemorrhoids', 'B', 'Neurogenic bladder: causes include spinal cord injury, MS, diabetic neuropathy, stroke, Parkinsons, spina bifida. Results in detrusor overactivity or underactivity, sphincter dyssynergia.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Management of neurogenic bladder includes:', 'Ignoring symptoms', 'Clean intermittent self-catheterization, antimuscarinics, and treating underlying condition', 'Immediate cystectomy', 'Dialysis', 'Observation only', 'B', 'Neurogenic bladder management: depends on type. Goals: preserve upper tracts, achieve continence. Options: CIC, indwelling catheter, antimuscarinics, Botox, augmentation cystoplasty, diversion.', 'medium', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Interstitial cystitis/bladder pain syndrome is characterized by:', 'Acute infection', 'Chronic pelvic pain related to bladder, with urgency/frequency, in absence of infection', 'Painless haematuria', 'Urinary retention', 'Fistula', 'B', 'IC/BPS: chronic (>6 weeks) bladder pain/discomfort with urinary symptoms, no infection or other identifiable cause. Diagnosis of exclusion. Treatment multimodal: dietary, oral, intravesical, neuromodulation.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bladder stones are most commonly associated with:', 'Kidney stones only', 'Bladder outlet obstruction, foreign bodies, or neurogenic bladder', 'Normal bladder function', 'Bladder cancer always', 'Young females', 'B', 'Bladder stones: most in adults due to BOO (BPH), neurogenic bladder, foreign body (catheters), diverticula. Primary stones (endemic) rare in developed countries. Composition variable.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment of bladder stones involves:', 'ESWL as first-line', 'Cystolitholapaxy (endoscopic fragmentation) and treating underlying cause', 'Antibiotics alone', 'Observation', 'Radiation', 'B', 'Bladder stone treatment: cystolitholapaxy (transurethral fragmentation and extraction) or open cystolithotomy for large stones. Must address underlying cause (e.g., BPH surgery).', 'medium', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Vesicovaginal fistula is most commonly caused by:', 'Infection', 'Obstetric injury (obstructed labour) or pelvic surgery', 'Bladder cancer', 'Trauma', 'Congenital', 'B', 'Vesicovaginal fistula: developing world - obstructed labour (prolonged pressure necrosis). Developed world - pelvic surgery (hysterectomy), radiation. Presents with continuous urinary leakage.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bladder diverticulum is:', 'Herniation of all bladder wall layers', 'Outpouching of mucosa through muscle defect', 'Congenital only', 'Always symptomatic', 'A type of cancer', 'B', 'Bladder diverticulum: mucosa herniates through muscle weakness. Acquired (BOO - most common) or congenital. May harbor stones, infection, rarely cancer (poor emptying). Treatment if symptomatic.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Acute urinary retention presents with:', 'Anuria without discomfort', 'Painful inability to void with distended bladder', 'Haematuria', 'Frequency', 'Stress incontinence', 'B', 'Acute retention: sudden inability to void, painful distended bladder, suprapubic tenderness. Requires urgent catheterization. Chronic retention: painless, high residual, overflow incontinence.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Causes of acute urinary retention in men include all EXCEPT:', 'BPH', 'Constipation', 'Medications (anticholinergics)', 'Increased fluid intake', 'Urethral stricture', 'D', 'Acute retention causes (men): BPH (most common), UTI, constipation, medications (anticholinergics, opioids, sympathomimetics), urethral stricture, prostate cancer. Increased fluids not a cause.', 'easy', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Initial management of acute urinary retention is:', 'Observation', 'Urethral or suprapubic catheterization', 'Alpha-blockers only', 'TURP', 'Antibiotics', 'B', 'Acute retention: urgent catheterization (urethral first-line). Monitor for post-obstructive diuresis if chronic. Trial without catheter after 2-3 days with alpha-blocker. Address underlying cause.', 'easy', 'application'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Post-obstructive diuresis occurs when:', 'Immediately after catheter removal', 'After relief of chronic urinary retention with mobilization of accumulated fluid/solutes', 'During active retention', 'Only in children', 'Never occurs', 'B', 'Post-obstructive diuresis: >200 mL/hour for several hours after relieving chronic retention. Due to accumulated urea (osmotic diuresis), pressure natriuresis, tubular dysfunction. Monitor fluids, electrolytes.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bladder exstrophy is:', 'Acquired condition', 'Congenital defect with bladder exposed on abdominal wall', 'Infection', 'Type of cancer', 'Neurogenic condition', 'B', 'Bladder exstrophy: failure of anterior abdominal wall and bladder closure. Bladder mucosa exposed. Associated with epispadias, pubic diastasis. Complex reconstruction required.', 'medium', 'knowledge'),

('c0000045-0000-0000-0000-000000000045'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bladder trauma is classified as:', 'Complete or incomplete', 'Intraperitoneal or extraperitoneal rupture', 'Anterior or posterior', 'Upper or lower', 'Acute or chronic', 'B', 'Bladder rupture: intraperitoneal (dome - requires surgical repair) or extraperitoneal (anterolateral - usually catheter drainage). Blunt trauma, pelvic fractures. CT cystogram diagnostic.', 'medium', 'knowledge');
